FDA Inspection 1238387 — Novo Nordisk A/S - Hax

Novo Nordisk A/S - Hax — FEI 3002807748

The FDA completed an inspection of Novo Nordisk A/S - Hax on June 1, 2023 in Gentofte. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 1, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Gentofte (Denmark)

Additional Details

Mutual Recognition Agreement (MRA)